About MiMedx Group, Inc. 
MiMedx Group, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 50 Schemes (17.58%)
Foreign Institutions
Held by 88 Foreign Institutions (5.14%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
114 Million
(Quarterly Results - Sep 2025)
Net Profit:
17 Million
Pharmaceuticals & Biotechnology
USD 789 Million (Small Cap)
24.00
NA
0.00%
-0.52
17.11%
3.30






